20 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
10 May 18
Bio-Path Holdings Appoints Dr. Anas Younes to Scientific Advisory Board
5:02pm
of Medicine. He completed his internal medicine residency training at SUNY Downstate Medical Center and his pathology residency at the Medical College of Ohio … . He completed his hematology fellowship training at MSK.
About Bio-Path Holdings, Inc.
Bio-Path is a biotechnology company developing DNAbilize®
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
26 Mar 14
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
12:00am
-University of Washington comprehensive cancer consortium including compliance, clinical staff training, regulatory affairs, protocol development
SB-2
EX-1
BPTH
Bio-Path Holdings Inc
8 May 03
Registration of securities for small business issuer
12:00am
. By accepting this Agreement, the
Participating Dealer has assumed full responsibility for thorough and proper
training of its
DEF 14A
BPTH
Bio-Path Holdings Inc
29 May 09
Definitive proxy
12:00am
is responsible for medical oversight, written policies, regulatory input, equipment selection, pharmaceuticals, training and other medically relevant issues
8-K
BPTH
Bio-Path Holdings Inc
19 Feb 08
Completion of Acquisition or Disposition of Assets
12:00am
for this growing national company. He is responsible for medical oversight, written policies, regulatory input, equipment selection, pharmaceuticals, training
SB-2
2w6z96
8 May 03
Registration of securities for small business issuer
12:00am
SB-2/A
nch76v
6 Aug 03
Registration of securities for small business issuer (amended)
12:00am
10-K
tk8ggw16ocdc6b
3 Apr 09
Annual report
12:00am
424B3
jovigmdwp0cmsu12w
1 Apr 11
Prospectus supplement
12:00am
424B3
69dqk4ix
30 Mar 12
Prospectus supplement
12:00am
424B3
i7j53kbxp8lu
29 Jul 10
Prospectus supplement
12:00am
S-1
8rsp2qmu
17 Jun 10
IPO registration
12:00am
- Prev
- 1
- Next